Other languages Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
6.22 ^USD	+0.32%		+7.99%	-31.80%

Mar. 20	Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing	MT
Mar. 19	Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing	Mar. 20
Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance	Mar. 19
Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics	Mar. 19
Cytek Biosciences Unveils New Manufacturing Facility in Wuxi, China	Mar. 08
Cytek Biosciences, Inc. Opens A New 50,000-Square-Foot Facility in Wuxi, China	Mar. 07
Cytek Biosciences, Inc. Provides Earnings Guidance for the Year Ended December 31, 2024	Mar. 01
Cytek Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28
Cytek Biosciences Agrees to Flow Cytometry Collaboration With Centre for Genomic Regulation, Pompeu Fabra University	Jan. 18
Cytek Biosciences, Inc. Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries	Jan. 17
Cytek Seeks Merger and Acquisitions	Jan. 11
Cytek Biosciences, Inc. Provides Revenue Guidance for the Year 2023	Jan. 08
Cytek Biosciences Introduces the Cytek Orion? Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry	Dec. 21
Cytek Biosciences Insider Sold Shares Worth $120,600, According to a Recent SEC Filing	Nov. 21
Cytek Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07
Cytek Biosciences, Inc. Provides Revenue Guidance for the Year 2023	Nov. 07
Cytek Biosciences Insider Sold Shares Worth $106,600, According to a Recent SEC Filing	23-10-12
Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services	23-08-28
Cytek Biosciences Reports Q2 Loss, Revenue Increases	23-08-09
Cytek Biosciences, Inc. Provides Revenue Guidance for the Full Year 2023	23-08-08
Cytek Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cytek Biosciences, Inc.

Equities

CTKB

US23285D1090

Other languages

Filters